Jefferies Financial Group Inc. decreased its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 60.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,611 shares of the company’s stock after selling 13,286 shares during the quarter. Jefferies Financial Group Inc.’s holdings in Cardinal Health were worth $1,916,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of CAH. Downshift Financial LLC raised its stake in Cardinal Health by 3,666.7% during the third quarter. Downshift Financial LLC now owns 113 shares of the company’s stock worth $25,000 after acquiring an additional 110 shares in the last quarter. Investors Research Corp acquired a new stake in shares of Cardinal Health in the 2nd quarter valued at $29,000. Maryland Capital Advisors Inc. grew its holdings in shares of Cardinal Health by 12,600.0% in the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock worth $28,000 after purchasing an additional 126 shares during the last quarter. Allied Private Wealth LLC bought a new stake in shares of Cardinal Health in the 2nd quarter worth about $30,000. Finally, NBH Bank bought a new position in Cardinal Health during the 2nd quarter valued at about $31,000. 87.17% of the stock is currently owned by institutional investors.
Cardinal Health Stock Up 0.2%
Shares of NYSE:CAH opened at $281.55 on Monday. Cardinal Health, Inc. has a 12 month low of $180.45 and a 12 month high of $286.29. The company’s 50-day moving average price is $244.15 and its two-hundred day moving average price is $225.24. The firm has a market cap of $65.08 billion, a P/E ratio of 36.42, a P/E/G ratio of 2.15 and a beta of 0.53.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $3.26 earnings per share for the quarter, beating the consensus estimate of $2.94 by $0.32. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm had revenue of $67.51 billion during the quarter, compared to analysts’ expectations of $66.67 billion. During the same quarter last year, the company posted $2.55 EPS. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. As a group, equities analysts predict that Cardinal Health, Inc. will post 12.97 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Monday, January 4th will be paid a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, January 4th. Cardinal Health’s dividend payout ratio is 26.65%.
Insiders Place Their Bets
In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. This represents a 8.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jason M. Hollar sold 44,529 shares of the stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total value of $10,516,859.22. Following the completion of the transaction, the chief executive officer owned 190,603 shares in the company, valued at $45,016,616.54. The trade was a 18.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 over the last quarter. Company insiders own 0.12% of the company’s stock.
Analyst Upgrades and Downgrades
CAH has been the topic of several research analyst reports. Robert W. Baird upped their price objective on shares of Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Argus raised their price objective on shares of Cardinal Health from $264.00 to $309.00 and gave the stock a “buy” rating in a report on Thursday. Leerink Partners set a $292.00 target price on shares of Cardinal Health in a research note on Tuesday, August 11th. Barclays boosted their target price on Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Finally, Morgan Stanley increased their price target on Cardinal Health from $265.00 to $286.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $279.44.
View Our Latest Stock Analysis on Cardinal Health
Cardinal Health Company Profile
Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.
See Also
- Five stocks we like better than Cardinal Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
